 |
 |

EXTENSIVE LABORATORY STUDIES OF A PATIENT WITH PHEOCHROMOCYTOMA BEFORE AND AFTER SUCCESSFUL OPERATIONWith a Note on the Trial of Piperidylmethyl Benzodioxane to Differentiate Such Conditions from Essential Hypertensive Vascular Disease
ROBERT W. WILKINS, M.D.;
WILLIAM E. R. GREER, M.D.;
JAMES W. CULBERTSON, M.D.;
MEYER H. HALPERIN, M.D.;
JULIUS LITTER, M.D.;
CHARLES H. BURNETT, M.D.;
REGINALD H. SMITHWICK, M.D.
Arch Intern Med. 1950;86(1):51-78.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
PHEOCHROMOCYTOMAS are tumors resulting from the abnormal proliferation of pheochromocytes, or mature cells of the endocrine series that arise from the primitive sympathogonia and normally form the endocrine portion of the adrenal medulla. These tumors may occur wherever there is chromaffin tissue but usually are observed in the medulla of the adrenal gland or in other retroperitoneal locations, such as the aortic chromaffin bodies (organ of Zuckerkandl) on the anterior surface of the aorta near its bifurcation. Characteristically they are localized benign tumors, although occasionally they undergo morphologic changes suggestive of malignant transformation.1 Their most interesting characteristic is their ability to produce physiopathologic changes, presumably through their excessive hormonal secretions. Therefore, their clinical manifestations are such that the patient frequently is thought to be suffering from a metabolic disease, and an erroneous diagnosis of thyrotoxicosis or diabetes mellitus is likely to be made.
In some patients with pheochromocytoma hypertensive
. . . [Full Text PDF of this Article]
Author Affiliations
BOSTON
From the Robert Dawson Evans Memorial, Massachusetts Memorial Hospitals, and the Departments of Medicine and Surgery, Boston University School of Medicine.
Footnotes
Dr. Culbertson was Public Health Service Special Research Fellow of the National Heart Institute. His present address is Department of Internal Medicine, State University of Iowa Hospitals, Iowa City. Dr. Litter is Life Insurance Medical Research Fellow.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|